Esophageal acid exposure at pH ≤ 2 is more common in Barrett's esophagus patients and is associated with oxidative stress

Diseases of the Esophagus

Volumn 19, Issue 5, 2006, Pages 366-372

  Dvorak, K ^a,b   Fass, R ^a,b   Dekel, R ^a,b   Payne, C M ^a,b   Chavarria, M ^a   Dvorakova, B ^a   Bernstein, H ^a   Bernstein, C ^a,b   Garewal, Harinder ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Apoptosis; Barrett's esophagus; Gastricacid; Oxidative stress

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS PH; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GASTROESOPHAGEAL REFLUX; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL LINE; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33748713465     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00596.x     Document Type: Article

References (38)

1. Devesa S S, Blot W J, Fraumeni J F Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
2. Shaheen N D F. Ransohoff, Gastroesophageal reflux, barrett esophagus, and esophageal cancer: Scientific review. Jama 2002; 287: 1972-81.
3. Falk G W. Barrett's esophagus. Gastroenterology 2002; 122: 1569-91.
4. Nehra D, Howell P, Williams C P et al. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity. Gut 1999; 44: 598-602.
5. Iftikhar S Y, Ledingham S, Steele R J et al. Bile reflux in columnar-lined Barrett's oesophagus. Ann R Coll Surg Engl 1993; 75: 411-16.
6. Dixon M F, Neville P M, Mapstone N P et al. Bile reflux gastritis and Barrett's oesophagus: Further evidence of a role for duodenogastro-oesophageal reflux? Gut 2001; 49: 359-63.
7. Vaezi M F, Richter J E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-9.
8. Kaur B S G. Triadafilopoulos, Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283: G327-34.
9. Souza R F, Shewmake K, Terada L S et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002; 122: 299-307.
10. Abdel-Latif M M, O'Riordan J, Windle H J et al. NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 2004; 239: 491-500.
11. Theisen J, Peters J H, Fein M et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005; 241: 63-8.
12. Sihvo E I, Ruohtula T, Auvinen M I et al. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. J Thorac Cardiovasc Surg 2003; 126: 1952-7.
13. Olyaee M, Sontag S, Salman W et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 1995; 37: 168-73.
14. Wetscher G J, Hinder P R, Bagchi D et al. Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995; 40: 1292-6.
15. Oh T Y, Lee J S, Ahn B O et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: Implication of antioxidants in its treatment. Free Radic Biol Med 2001; 30: 905-15.
16. Sihvo E I, Salminen J T, Rantanen T K et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer, 2002; 102: 551-5.
17. Chen X, Ding Y W, Yang G et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000; 21: 257-63.
18. Wetscher G J, Hinder R A, Klingler P et al. Reflux esophagitis in humans is a free radical event. Dis Esophagus 1997; 10: 29-32; discussion 33.
19. Wetscher G J, Hinder R A, Bagchi D et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170: 552-6; discussion 556-7.
20. Yu H R. Jove, The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 2004; 4: 97-105.
21. Angelo L S, Talpaz M, Kurzrock R. Autocrine interleukin-6 production in renal cell carcinoma: Evidence for the involvement of p53. Cancer Res 2002; 62: 932-40.
22. Torres M H J. Forman, Redox signaling and the MAP kinase pathways. Biofactors 2003; 17: 287-96.
23. Bernstein H, Payne C M, Kunke K et al. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 2004; 25: 681-92.
24. Dvorakova K, Payne C M, Ramsey L et al. Apoptosis resistance in Barrett's esophagus: Ex vivo bioassay of live stressed tissues. Am J Gastroenterol 2005; 100: 424-31.
25. Younes M, Lechago J, Ertan A et al. Decreased expression of Fas (CD95/ APO1) associated with goblet cell metaplasia in Barrett's esophagus. Hum Pathol 2000; 31: 434-8.
26. Whittles C E, Biddlestone L R, Burton A et al. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study. J Pathol 1999; 187: 535-40.
27. Soslow R A, Remotti H, Baergen R N et al. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus. Mod Pathol 1999; 12: 239-50.
28. Katada N, Hinder R A, Smyrk T C et al. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus. Arch Surg 1997; 132: 728-33.
29. Stoner G D, Kaighn M E, Reddel R R et al. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res 1991; 51: 365-71.
30. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-19.
31. Dvorakova K, Waltmire C N, Payne C M et al. Induction of mitochondrial changes in myeloma cells by imexon. Blood 2001; 97: 3544-51.
32. Martinez S D, Malagon I B, Garewal H S et al. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-45.
33. Cameron A J. Barrett's esophagus: Prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 2054-9.
34. Kahrilas P J, Dodds W J, Hogan W J. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988; 94: 73-80.
35. Parkman H P R S. Fisher, Contributing role of motility abnormalities in the pathogenesis of gastroesophageal reflux disease. Dig Dis 1997; 15: 40-52.
36. Wetscher G J, Perdikis G, Kretchmar D H et al. Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995; 40: 1297-305.
37. Terry P, Lagergren J, Ye W et al. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000; 87: 750-4.
38. Natale G, Lazzeri G, Lubrano V et al. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds. Toxicol Appl Pharmacol 2004; 195: 62-72.